David E Vaillancourt Selected Research

Choline O-Acetyltransferase (Choline Acetyltransferase)

1/2021

Alteration of the cholinergic system and motor deficits in cholinergic neuron-specific Dyt1 knockout mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David E Vaillancourt Research Topics

Disease

22	Parkinson Disease (Parkinson's Disease) 01/2022 - 03/2004
8	Dystonia (Limb Dystonia) 01/2021 - 06/2014
7	Parkinsonian Disorders (Parkinsonism) 01/2020 - 11/2013
6	Dystonia musculorum deformans type 1 01/2021 - 10/2017
5	Disease Progression 01/2022 - 08/2016
4	Tremor (Tremors) 01/2013 - 09/2004
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2016
3	Hypokinesia (Bradykinesia) 04/2016 - 03/2004
2	Movement Disorders (Movement Disorder) 06/2014 - 08/2011
1	Brain Concussion (Cerebral Concussion) 01/2022
1	Cognitive Dysfunction 01/2022
1	Neurodevelopmental Disorders 01/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022
1	Atrophy 01/2022
1	Prodromal Symptoms 10/2021
1	Synucleinopathies 01/2020
1	Dementia (Dementias) 01/2020
1	Multiple System Atrophy 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Amyloidosis 11/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Torticollis (Wryneck) 12/2018
1	Dyskinesias (Dyskinesia) 04/2016
1	Neurobehavioral Manifestations 01/2016
1	Pain (Aches) 01/2015
1	Essential Tremor (Essential Tremors) 08/2011

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2013
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2017
5	Pharmaceutical PreparationsIBA 01/2021 - 12/2010
4	Levodopa (L Dopa)FDA LinkGeneric 01/2018 - 12/2013
3	Cholinergic Agents (Cholinergics)IBA 01/2021 - 10/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2021
2	rasagiline (Azilect)FDA Link 01/2022 - 01/2016
2	neuromelaninIBA 10/2021 - 10/2018
2	IronIBA 10/2021 - 10/2018
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2021
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2021 - 01/2020
2	SynucleinsIBA 01/2020 - 01/2018
1	Chitinase-3-Like Protein 1IBA 01/2022
1	visininIBA 01/2022
1	Nicotine FDA Link 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Synaptosomal-Associated Protein 25IBA 01/2022
1	NeurograninIBA 01/2022
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2021
1	florbetapirIBA 01/2021
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 01/2021
1	MuscarineIBA 01/2021
1	Neomycin FDA LinkGeneric 01/2021
1	HIV Protease InhibitorsIBA 01/2021
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021
1	QuinpiroleIBA 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	PotassiumIBA 12/2020
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 12/2020
1	CalciumIBA 12/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2020
1	TropomyosinIBA 01/2020
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	EnzymesIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	Prednisolone (Predate)FDA LinkGeneric 11/2018
1	Muscarinic AntagonistsIBA 10/2017
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 08/2017
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2017
1	Trihexyphenidyl (Artane)FDA LinkGeneric 01/2017
1	aducanumabIBA 11/2016
1	Monoamine Oxidase (MAO)IBA 01/2016
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2016
1	phenylsaligenin cyclic phosphate (PSCP)IBA 01/2015
1	Dopamine (Intropin)FDA LinkGeneric 12/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2013

Therapy/Procedure

8	Deep Brain Stimulation 12/2018 - 03/2004
7	Therapeutics 01/2022 - 03/2004
3	Transcranial Magnetic Stimulation 12/2018 - 06/2014
2	Electrodes (Electrode) 01/2006 - 03/2004
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2019
1	Activities of Daily Living (ADL) 08/2011